Which medications can cause false‑positive elevations or analytical interference when measuring plasma metanephrines?

Medications That Interfere with Plasma Metanephrine Measurement

Medications that directly interfere with measurement methods (acetaminophen, mesalamine, sulfasalazine when using LC-ECD methods) or interfere with catecholamine disposition (tricyclic antidepressants, norepinephrine reuptake blockers) can cause mildly to markedly elevated plasma metanephrine results. 1

Two Categories of Drug Interference

1. Analytical Interference (Direct Assay Interference)

These drugs physically interfere with the measurement method itself:

• Acetaminophen - causes analytical interference with LC-ECD methods 1
• Mesalamine - interferes with LC-ECD methods 1
• Sulfasalazine - interferes with LC-ECD methods 1
• Midodrine - its metabolite desglymidodrine co-elutes with metanephrine on LC-MS/MS, causing falsely elevated plasma metanephrine (not normetanephrine) 2

2. Physiological Interference (Catecholamine Disposition)

These drugs alter catecholamine metabolism and clearance, causing true elevations in circulating metanephrines:

Norepinephrine Reuptake Blockers (NRBs) are the most clinically significant:

• Tricyclic antidepressants - increase plasma normetanephrine by 40% and methoxytyramine by 127%, with false-positive rates rising from 4.8% to 23% for normetanephrine and 0.9% to 28.6% for methoxytyramine 3
• Serotonin-norepinephrine reuptake inhibitors (SNRIs) - similarly elevate normetanephrine and methoxytyramine in a dose-dependent manner 4, 3

The most recent high-quality evidence 4 from 2026 demonstrates that NRBs are the only drugs independently associated with increased plasma free normetanephrine in multivariable analysis (P < 0.001), and this effect is dose-dependent. Importantly, NRBs also independently influence methoxytyramine concentrations 4.

Critical Clinical Nuances

The magnitude of elevation matters: While NRBs typically cause mild elevations, rare exceptions exist where normetanephrine and methoxytyramine can reach pathological levels exceeding 6 times the upper reference limit 3. This may reflect failure of centrally mediated sympathoinhibition that normally occurs with norepinephrine reuptake blockade.

Reversibility confirms the diagnosis: When NRBs are discontinued short-term, plasma normetanephrine normalizes 4, 3, providing a practical diagnostic strategy for borderline elevations.

Antipsychotics and nicotine also independently influence methoxytyramine concentrations 4, though their effect on normetanephrine is less pronounced.

Drugs That Do NOT Interfere

Common antihypertensive agents do not affect plasma metanephrines: Beta-blockers, thiazide diuretics, and ACE inhibitors show no significant impact on plasma free metanephrine or normetanephrine concentrations when measured by LC-MS/MS 5. Withdrawal of these medications prior to testing is unnecessary.

Selective serotonin reuptake inhibitors (SSRIs) do not increase plasma concentrations of metanephrines 3, distinguishing them from SNRIs.

Practical Management Algorithm

1. Review medication list before interpreting elevated plasma metanephrines
2. If patient is on NRBs (tricyclics or SNRIs):
   • Recognize 23-28% false-positive rate for normetanephrine/methoxytyramine
   • Consider short-term discontinuation (if medically safe) and repeat testing
   • If discontinuation impossible, use urinary fractionated metanephrines as alternative
3. If patient is on acetaminophen, mesalamine, sulfasalazine:
   • Verify laboratory uses LC-MS/MS (not LC-ECD) to avoid analytical interference
   • If LC-ECD is used, discontinue medication or switch to urinary testing
4. If patient is on midodrine:
   • Expect falsely elevated metanephrine (not normetanephrine)
   • Discontinue and retest, or use clinical context to exclude pheochromocytoma
5. If patient is on beta-blockers, diuretics, ACE inhibitors, or SSRIs:
   • Proceed with testing without medication adjustment

Common Pitfalls to Avoid

Do not assume all antidepressants cause interference - only those with norepinephrine reuptake blocking properties (tricyclics and SNRIs) cause problems; SSRIs are safe 3.

Do not unnecessarily discontinue antihypertensives - beta-blockers, diuretics, and ACE inhibitors do not require withdrawal 5, contrary to older teaching.

Recognize assay-specific interference - acetaminophen, mesalamine, and sulfasalazine only interfere with LC-ECD methods, not LC-MS/MS 1. Know which method your laboratory uses.

Consider physiological stress and critical illness as additional causes of false-positive elevations beyond medications 1.